Cabaletta Bio is trading 5% up at $2.88, most likely reflecting broader risk-on market sentiment after rebounding from a 5.84% decline on September 10.
- Major U.S. indexes are up more than 0.5%.
- No new company-specific announcement was identified for September 11.
- Latest notable coverage concerned management’s September 9 healthcare-conference presentation on rese-cel safety and manufacturing progress.